Joanne Hackett
Corporate Officer/Principal bei IQVIA HOLDINGS INC.
Aktive Positionen von Joanne Hackett
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| IQVIA HOLDINGS INC. | Corporate Officer/Principal | - | - |
Karriereverlauf von Joanne Hackett
Ehemalige bekannte Positionen von Joanne Hackett
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Genomics England Ltd.
 Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Genomics England Ltd. runs and delivers 100,000 genomes project. Its flagship project sequences 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. The company was founded by Jeremy Hunt on July 5, 2013 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 01.01.2017 | 01.01.2020 |
Precision Medicine Catapult
 Precision Medicine Catapult BiotechnologyHealth Technology Precision Medicine Catapult is a British company that engages in the research and development of biotechnology. The private company is based in Oxford, UK. | Vorstandsvorsitzender | 01.01.2016 | 01.01.2017 |
UCL Partners Ltd.
 UCL Partners Ltd. Medical/Nursing ServicesHealth Services UCL Partners Ltd. is a British company that supports health and care improvements. The private company is based in London, UK. The company was founded in 2009. Charlie Davie has been the CEO of the company since 2009. | Corporate Officer/Principal | 01.01.2013 | 01.01.2016 |
| Cambridge University Health Partners | Geschäftsführer | - | - |
| AGEX THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 29.12.2021 | 18.05.2022 |
| Vorstandsvorsitzender | - | - | |
| Vorsitzender | 18.05.2022 | - | |
| Independent Dir/Board Member | 29.12.2021 | - |
Ausbildung von Joanne Hackett
| University of New Brunswick | Doctorate Degree |
Statistik
International
| Vereinigtes Königreich | 5 |
| Vereinigte Staaten | 3 |
| Kanada | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 2 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 3 |
| Health Services | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IQVIA HOLDINGS INC. | Health Services |
| Private Unternehmen | 5 |
|---|---|
AgeX Therapeutics, Inc.
 AgeX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AgeX Therapeutics, Inc. operates as a biotechnology company, which engages in the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Its product pipeline includes AGEX-VASC1, AGEX-BAT1, and AGEX-iTR1547. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA. | Health Technology |
Genomics England Ltd.
Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Genomics England Ltd. runs and delivers 100,000 genomes project. Its flagship project sequences 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. The company was founded by Jeremy Hunt on July 5, 2013 and is headquartered in London, the United Kingdom. | Commercial Services |
Precision Medicine Catapult
Precision Medicine Catapult BiotechnologyHealth Technology Precision Medicine Catapult is a British company that engages in the research and development of biotechnology. The private company is based in Oxford, UK. | Health Technology |
| Cambridge University Health Partners | |
UCL Partners Ltd.
UCL Partners Ltd. Medical/Nursing ServicesHealth Services UCL Partners Ltd. is a British company that supports health and care improvements. The private company is based in London, UK. The company was founded in 2009. Charlie Davie has been the CEO of the company since 2009. | Health Services |
- Börse
- Insiders
- Joanne Hackett
- Erfahrung
